News | July 23, 2014

Young Women With Heart Attacks Continue to Fare Worse Than Men

heart attacks, women's health

While awareness campaigns may be getting women to go to the hospital more quickly during a heart-attack, a new look at hospital data shows women have longer hospital stays and are more likely than men to die in the hospital after a heart attack. In the study published online in the Journal of the American College of Cardiology, researchers from Yale School of Medicine analyzed 230,684 hospitalizations for heart attack in patients age 30 to 54 from a total of 1.1 million hospitalizations reported in a national database from 2001 to 2010. The study found that heart attack hospitalization rates for patients under age 55 have not declined as quickly as they have for Medicare-age patients, which have seen a 20 percent drop. 
 
“This trend suggests we need to raise awareness of the importance of controlling cardiovascular risk factors like diabetes, high blood pressure and smoking in younger patients,” said lead author Aakriti Gupta, M.D.
 
All patient groups in the study saw increases in coexisting medical conditions including high blood pressure and diabetes. Men were more likely to have high cholesterol while women, especially black women, were more likely to also have hypertension, diabetes and heart failure. The authors concluded that younger women may benefit from more aggressive control of modifiable cardiovascular risk factors, including early identification and treatment of high blood pressure, high cholesterol, obesity, smoking and diabetes.
 
“Younger women are a vulnerable yet understudied group with worse cardiac risk profiles and worse outcomes after a heart attack as compared with younger men,” Gupta said. 
 
For more information: www.cardiosource.org/acc

Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now